Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Recombinant incretin injection in type 2 diabetes
CTR20150401Phase 2Completed
- Sponsor
- Dongguan Baolijian Biotech
- Start
- Jun 2015
- Modality
- Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of beinaglutide in type 2 diabetes mellitus (T2DM), sponsored by Dongguan Baolijian Biotech. Started Jun 2015; status: completed.
02
Drugs
beinaglutide
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on CTR20150401.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20150401.